Cargando…

HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly

SIMPLE SUMMARY: This study investigated HCC onset in a cohort of patients receiving DAA therapy for HCV infection. It highlights that HCC onset after HCV-clearance might show more aggressive behavior and might exclude the patient from curative treatments, such as surgery or radiofrequency ablation....

Descripción completa

Detalles Bibliográficos
Autores principales:	Brozzetti, Stefania, Tancredi, Marsia, Bini, Simone, De Lucia, Chiara, Antimi, Jessica, D’Alterio, Chiara, De Sanctis, Giuseppe Maria, Furlan, Caterina, Malpassuti, Vittoria Carolina, Lucatelli, Pierleone, Di Martino, Michele, Bezzi, Mario, Ciardi, Antonio, Pascale, Rosa Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235445/ https://www.ncbi.nlm.nih.gov/pubmed/34204186 http://dx.doi.org/10.3390/cancers13123025

Ejemplares similares

Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients—A Retrospective Observational Study
por: Brozzetti, Stefania, et al.
Publicado: (2022)

Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC
por: Gao, Xiuzhu, et al.
Publicado: (2020)

Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Case-report: Metastases in a low-stage middle-graded HCC in cleared HCV infection, non-cirrhotic liver: Surgical therapy
por: Brozzetti, Stefania, et al.
Publicado: (2018)

Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA
por: Hosui, Atsushi, et al.
Publicado: (2021)

Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
por: Pascut, Devis, et al.
Publicado: (2020)

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study
por: Morisco, Filomena, et al.
Publicado: (2021)

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
por: Kanda, Tatsuo, et al.
Publicado: (2019)

The Impact of Hepatitis C Virus (HCV) Treatment with Direct-Acting (DAA) on the Incidence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Liver Disease
por: De Comarmond, Charles, et al.
Publicado: (2017)

Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis
por: Golfieri, Rita, et al.
Publicado: (2021)

Use of Phil Embolic Agent for Bleeding in Non-Neurological Interventions
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results
por: Lucatelli, Pierleone, et al.
Publicado: (2019)

CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
por: Neve Polimeno, Maria, et al.
Publicado: (2015)

Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study
por: Ciancio, Alessia, et al.
Publicado: (2023)

Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
por: Salum, Ghada M., et al.
Publicado: (2019)

Locoregional therapy response in patients with hepatocellular cancer waiting for liver transplantation: Only selection or biological effect?
por: Lai, Quirino, et al.
Publicado: (2018)

Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy)
por: Scaglione, Vincenzo, et al.
Publicado: (2020)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021)

Case Report: Solitary metastasis to the appendix after curative treatment of HCC
por: Zhang, Zun-Yi, et al.
Publicado: (2023)

Effects of percutaneous varicocele repair on testicular volume: results from a 12-month follow-up
por: Sansone, Andrea, et al.
Publicado: (2019)

Splenic Artery Pseudoaneurysms: The Role of ce-CT for Diagnosis and Treatment Planning
por: Corvino, Fabio, et al.
Publicado: (2022)

Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients
por: Parisse, Simona, et al.
Publicado: (2021)

Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs
por: Søholm, Jacob, et al.
Publicado: (2020)

Proposed algorithm during COVID-19 pandemic for patient management in medical retina clinic
por: Corazza, Paolo, et al.
Publicado: (2020)

(18)F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches
por: Kornberg, Arno, et al.
Publicado: (2019)

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs
por: Paolucci, Stefania, et al.
Publicado: (2017)

Chinese expert consensus on technical recommendations for the standard operation of drug-eluting beads for transvascular embolization
por: Shao, Guoliang, et al.
Publicado: (2021)

Clinical outcomes of DAA and related techniques in hip arthroplasty
por: Driesman, Adam, et al.
Publicado: (2023)

Microballoon Interventions for Liver Tumors: Review of Literature and Future Perspectives
por: Lucatelli, Pierleone, et al.
Publicado: (2022)

Case report and literature review: Isolated HCC- recurrence in gallbladder after curative resection
por: Zhang, Shi-Ran, et al.
Publicado: (2023)

Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance
por: Franzè, Maria Stella, et al.
Publicado: (2022)

Occupational Mortality Matrix: A Tool for Epidemiological Assessment of Work-Related Risk Based on Current Data Sources
por: Massari, Stefania, et al.
Publicado: (2022)

Treatment of hepatitis C in HIV patients in the new DAA era
por: Soriano, Vicente
Publicado: (2014)

Is DAA Treatment Associated with HBV Reactivation? Results from ERCHIVES
por: Butt, Adeel, et al.
Publicado: (2017)

Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018)

Treatment and re-treatment results of HCV patients in the DAA era
por: Piecha, Felix, et al.
Publicado: (2020)

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
por: Danishwar, Mahmood, et al.
Publicado: (2022)

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
por: de Gennaro, Nicolò, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8nsu0kgh7hqqc7h2l7n3pnggsh